COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,241 Articles (22,733 medRxiv, 8,508 bioRxiv)

Most recent first Previous |  Page 815: Articles 8141-8150  | Next

BCG vaccination of Diversity Outbred mice induces cross-reactive antibodies to SARS-CoV-2 spike protein
Specht, A. G., Kurtz, S. L., Elkins, K. L., Specht, H., Beamer, G.
10.1101/2022.04.18.488640 — Posted: 2022-04-19
An intranasal nanoparticle STING agonist has broad protective immunity against respiratory viruses and variants
Leekha, A., Saeedi, A., Kumar, M., Sefat, S. R., Paniagua, M. M., Fathi, M., Kulkarni, R., Biswas, S., Tsitoura, D., Liu, X., Cooper, L. J. N., Sebastian, M., Hurst, B. L., Varadarajan, N.
10.1101/2022.04.18.488695 — Posted: 2022-04-19
The Dawn is Coming -- the Description and Prediction of Omicron SARS-CoV-2 Epidemic Outbreak in Shanghai by Mathematical Modeling
Jiang, M., Meng, G., Wu, G.
10.1101/2022.04.13.22273788 — Posted: 2022-04-19
Read2Tree: scalable and accurate phylogenetic trees from raw reads
Dylus, D., Altenhoff, A. M., Majidian, S., Sedlazeck, F. J., Dessimoz, C.
10.1101/2022.04.18.488678 — Posted: 2022-04-19
Persistent cross-species SARS-CoV-2 variant infectivity predicted via comparative molecular dynamics simulation
Rajendran, M., Babbitt, G. A.
10.1101/2022.04.18.488629 — Posted: 2022-04-19
Redox regulation of the SARS-CoV-2 main protease provides new opportunities for drug design
Tittmann, K., Funk, L.-M., Poschmann, G., Chari, A., Rabe von Pappenheim, F., Stegmann, K. M., Dickmanns, A., Eulig, N., Wensien, M., Paknia, E., Heyne, G., Penka, E., Pearson, A. R., Berndt, C., Fritz, T., Bazzi, S., Uranga, J., Mata, R. A., Dobbelstein, M., Hilgenfeld, R., Curth, U.
10.1101/2022.04.18.487732 — Posted: 2022-04-19
Elucidating host cell response pathways and repurposing therapeutics for SARS-CoV-2 and other coronaviruses using gene expression profiles of chemical and genetic perturbations
Shen, Z., Halberg, A., Fong, J. Y., Guo, J., Song, G., Louie, B., Luedtke, G. R., Visuthikraisee, V., Protter, A., Koh, X., Baik, T., Lum, P. Y.
10.1101/2022.04.18.488682 — Posted: 2022-04-19
Vγ9Vδ2 T cells are potent inhibitors of SARS-CoV-2 replication and exert effector phenotypes in COVID-19 patients
Gay, L., Rouviere, M.-S., Mezouar, S., Richaud, M., Gorvel, L., Foucher, E., Madakamutil, L., La Scola, B., Menard, A., Allardet-Servent, J., Halfon, P., Frohna, P., Cano, C., Mege, J.-L., Olive, D.
10.1101/2022.04.15.487518 — Posted: 2022-04-19
Pathogen- and type-specific changes in invasive bacterial disease epidemiology during the first year of the COVID-19 pandemic in the Netherlands
Steens, A., Knol, M. J., Freudenburg-de Graaf, W., de Melker, H. E., van der Ende, A., van Sorge, N. M.
10.1101/2022.04.19.22273034 — Posted: 2022-04-19
An Evaluation of Prospective COVID-19 Modeling: From Data to Science Translation
Nixon, K., Jindal, S., Parker, F., Reich, N. G., Lee, E. C., Truelove, S., Gardner, L.
10.1101/2022.04.18.22273992 — Posted: 2022-04-19

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).